| $370M | ||
| $337M | ||
| $259M | ||
| $100M | ||
| $79M | ||
| $62M |
Buys | $0 | 0 | 0 |
Sells | $3,531 | 2 | 100 |
| Chiang Pichi Luo | SVP, Corporate Controller | 0 | $0 | 1 | $1,130 | $-1,130 |
| Schiller Mark C. | Chief Operating Officer | 0 | $0 | 1 | $2,401 | $-2,401 |
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products …
Over the last 12 months, insiders at Kezar Life Sciences, Inc. have bought $0 and sold $3,531 worth of Kezar Life Sciences, Inc. stock.
On average, over the past 5 years, insiders at Kezar Life Sciences, Inc. have bought $295,400 and sold $980,348 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $295,400 was made by BERGER FRANKLIN M () on 2022‑03‑18.
| 2025-07-02 | Sale | Schiller Mark C. | Chief Operating Officer | 561 0.0073% | $4.28 | $2,401 | -9.35% | |
| 2025-07-02 | Sale | Chiang Pichi Luo | SVP, Corporate Controller | 264 0.0034% | $4.28 | $1,130 | -9.35% | |
| 2024-07-02 | Sale | Schiller Mark C. | Chief Legal Officer | 6,688 0.0084% | $0.58 | $3,879 | -88.48% | |
| 2023-02-06 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 40,000 0.0558% | $6.88 | $275,320 | -69.99% | |
| 2023-02-03 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 25,000 0.0348% | $7.15 | $178,650 | -70.14% | |
| 2023-02-02 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 50,000 0.0681% | $7.19 | $359,500 | -70.86% | |
| 2023-02-01 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 40,000 0.0558% | $6.95 | $278,000 | -68.99% | |
| 2023-01-31 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 30,000 0.041% | $7.08 | $212,400 | -70.01% | |
| 2023-01-30 | Sale | Morningside Venture Investments Ltd | 10 percent owner | 30,000 0.041% | $6.91 | $207,300 | -68.71% | |
| 2023-01-25 | Sale | Morningside Venture Investments Ltd | director | 50,000 0.0697% | $6.85 | $342,500 | -67.35% | |
| 2023-01-24 | Sale | Morningside Venture Investments Ltd | director | 80,000 0.1103% | $6.98 | $558,400 | -68.05% | |
| 2023-01-23 | Sale | Morningside Venture Investments Ltd | director | 80,000 0.1109% | $6.81 | $544,800 | -66.76% | |
| 2023-01-17 | Sale | Morningside Venture Investments Ltd | director | 6,114 0.0088% | $6.79 | $41,514 | -64.18% | |
| 2023-01-13 | Sale | Morningside Venture Investments Ltd | director | 1,971 0.0029% | $7.15 | $14,093 | -65.50% | |
| 2023-01-12 | Sale | Morningside Venture Investments Ltd | director | 5,000 0.0068% | $6.77 | $33,850 | -65.80% | |
| 2023-01-06 | Sale | Morningside Venture Investments Ltd | director | 3,000 0.0042% | $6.89 | $20,670 | -65.20% | |
| 2023-01-05 | Sale | Morningside Venture Investments Ltd | director | 12,162 0.017% | $6.97 | $84,769 | -65.51% | |
| 2023-01-04 | Sale | Morningside Venture Investments Ltd | director | 30,000 0.0414% | $7.17 | $215,100 | -66.90% | |
| 2023-01-03 | Sale | Morningside Venture Investments Ltd | director | 500 0.0007% | $7.10 | $3,550 | -65.66% | |
| 2022-12-29 | Sale | Morningside Venture Investments Ltd | director | 25,000 0.0375% | $7.10 | $177,500 | -66.15% |
| Equal Talent Investments Ltd | 10 percent owner | 6254545 85.4083% | $25.46M | 1 | 0 | +13.64% |
| Morningside Venture Investments Ltd | 10 percent owner | 5447993 74.3945% | $22.17M | 2 | 19 | +69.08% |
| Cormorant Asset Management, LP | 10 percent owner | 1572909 21.4787% | $6.4M | 1 | 0 | |
| BERGER FRANKLIN M | 890691 12.1627% | $3.63M | 4 | 0 | +10.22% | |
| BAY CITY CAPITAL LLC | 10 percent owner | 622229 8.4968% | $2.53M | 1 | 0 | |
| Kirk Christopher J. | President and CSO | 342609 4.6785% | $1.39M | 3 | 0 | +69.08% |
| Fowler John Franklin | CEO | 38461 0.5252% | $156,536.27 | 4 | 0 | +55.28% |
| Belsky Marc | CFO | 15384 0.2101% | $62,612.88 | 6 | 0 | +71.3% |
| Economides Vassiliki | SVP, Strategy & External Aff. | 7570 0.1034% | $30,809.90 | 5 | 0 | +69.08% |
$53,490,060 | 55 | 19.35% | $36.25M | |
$6,204,522 | 45 | 1.91% | $23.95M | |
$395,438 | 43 | -21.25% | $29.72M | |
$22,323,743 | 39 | 23.92% | $27.16M | |
$459,011,221 | 33 | 33.04% | $34.04M |
| Increased Positions | 13 | +28.89% | 324,299 | +7.48% |
| Decreased Positions | 13 | -28.89% | 181,934 | -4.2% |
| New Positions | 2 | New | 188 | New |
| Sold Out Positions | 5 | Sold Out | 93,354 | Sold Out |
| Total Postitions | 45 | 0% | 4M | +3.29% |
| Tang Capital Management Llc | $2,844.00 | 10.29% | 720,000 | 0 | 0% | 2025-06-30 |
| Suvretta Capital Management, Llc | $2,831.00 | 10.24% | 716,759 | 0 | 0% | 2025-06-30 |
| Bml Capital Management, Llc | $2,509.00 | 9.07% | 635,183 | +227,045 | +55.63% | 2025-06-30 |
| Avidity Partners Management Lp | $1,985.00 | 7.18% | 502,600 | 0 | 0% | 2025-06-30 |
| Vanguard Group Inc | $1,091.00 | 3.95% | 276,228 | 0 | 0% | 2025-06-30 |
| Orbimed Advisors Llc | $761.00 | 2.75% | 192,700 | 0 | 0% | 2025-06-30 |
| Stonepine Capital Management, Llc | $671.00 | 2.43% | 169,859 | +69,859 | +69.86% | 2025-06-30 |
| Adar1 Capital Management, Llc | $582.00 | 2.11% | 147,404 | 0 | 0% | 2025-06-30 |
| Acadian Asset Management Llc | $527.00 | 1.91% | 133,525 | 0 | 0% | 2025-06-30 |
| Peapod Lane Capital Llc | $455.00 | 1.65% | 115,123 | -9,304 | -7.48% | 2025-06-30 |